Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice
- PMID: 33451301
- PMCID: PMC7811255
- DOI: 10.1186/s12868-020-00606-z
Post-status epilepticus treatment with the Fyn inhibitor, saracatinib, improves cognitive function in mice
Abstract
Background: Status epilepticus (SE) is a life-threatening neurological disorder. The hippocampus, as an important area of the brain that regulates cognitive function, is usually damaged after SE, and cognitive deficits often result from hippocampal neurons lost after SE. Fyn, a non-receptor Src family of tyrosine kinases, is potentially associated with the onset of seizure. Saracatinib, a Fyn inhibitor, suppresses epileptogenesis and reduces epileptiform spikes. However, whether saracatinib inhibits cognitive deficits after SE is still unknown.
Methods: In the present study, a pilocarpine-induced SE mouse model was used to answer this question by using the Morris water maze and normal object recognition behavioral tests.
Results: We found that saracatinib inhibited the loss in cognitive function following SE. Furthermore, we found that the number of hippocampal neurons in the saracatinib treatment group was increased, when compared to the SE group.
Conclusions: These results showed that saracatinib can improve cognitive functions by reducing the loss of hippocampal neurons after SE, suggesting that Fyn dysfunction is involved in cognitive deficits after SE, and that the inhibition of Fyn is a possible treatment to improve cognitive function in SE patients.
Keywords: Cognitive function; Fyn inhibitor; Hippocampal neurons; Saracatinib; Status epilepticus.
Conflict of interest statement
All authors declare that they have no competing interests.
Figures




Similar articles
-
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.Neurobiol Dis. 2021 Aug;156:105410. doi: 10.1016/j.nbd.2021.105410. Epub 2021 Jun 1. Neurobiol Dis. 2021. PMID: 34087381 Free PMC article.
-
Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy.Neurobiol Dis. 2018 Feb;110:102-121. doi: 10.1016/j.nbd.2017.11.008. Epub 2017 Nov 29. Neurobiol Dis. 2018. PMID: 29197620 Free PMC article.
-
Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.Cell Death Dis. 2020 Feb 12;11(2):118. doi: 10.1038/s41419-020-2229-2. Cell Death Dis. 2020. PMID: 32051399 Free PMC article.
-
Targeting Fyn Kinase in Alzheimer's Disease.Biol Psychiatry. 2018 Feb 15;83(4):369-376. doi: 10.1016/j.biopsych.2017.06.004. Epub 2017 Jun 13. Biol Psychiatry. 2018. PMID: 28709498 Free PMC article. Review.
-
Dual Drug Repurposing: The Example of Saracatinib.Int J Mol Sci. 2024 Apr 22;25(8):4565. doi: 10.3390/ijms25084565. Int J Mol Sci. 2024. PMID: 38674150 Free PMC article. Review.
Cited by
-
Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice.Int J Mol Sci. 2021 Mar 22;22(6):3240. doi: 10.3390/ijms22063240. Int J Mol Sci. 2021. PMID: 33810180 Free PMC article.
-
Gut dysbiosis following organophosphate, diisopropylfluorophosphate (DFP), intoxication and saracatinib oral administration.Front Microbiomes. 2022;1:1006078. doi: 10.3389/frmbi.2022.1006078. Epub 2022 Oct 20. Front Microbiomes. 2022. PMID: 37304619 Free PMC article.
-
Changes in the Proteomic Profile After Audiogenic Kindling in the Inferior Colliculus of the GASH/Sal Model of Epilepsy.Int J Mol Sci. 2025 Mar 5;26(5):2331. doi: 10.3390/ijms26052331. Int J Mol Sci. 2025. PMID: 40076950 Free PMC article.
-
Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare.Front Vet Sci. 2023 Nov 9;10:1297221. doi: 10.3389/fvets.2023.1297221. eCollection 2023. Front Vet Sci. 2023. PMID: 38026620 Free PMC article.
-
Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy.Neurobiol Dis. 2021 Aug;156:105410. doi: 10.1016/j.nbd.2021.105410. Epub 2021 Jun 1. Neurobiol Dis. 2021. PMID: 34087381 Free PMC article.
References
-
- Zhu X, Yao Y, Yang J, Ge Q, Niu D, Liu X, Zhang C, Gan G, Zhang A, Yao H. Seizure-induced neuroinflammation contributes to ectopic neurogenesis and aggressive behavior in pilocarpine-induced status epilepticus mice. Neuropharmacology. 2020;170:108044. doi: 10.1016/j.neuropharm.2020.108044. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous